Objectives:The present study evaluated the changes in serology and human immunodeficiency virus (HIV) testing behaviors over a 10-year period in a center in India.Methods:We used clinical data collected at the antenatal clinic from 2002 to 2011. The key outcomes were: (1) Proportion of women who opted for HIV test and those who tested positive; (2) proportion of male partners who came in for HIV test and those who tested positive; and (3) proportion of women who opted for continuation of pregnancy or for medical termination of pregnancy.Results:We tested 11,452 women for HIV over the 10-year period from 2002 to 2011. The proportion of women who opted for HIV testing was 72.0% (95% confidence interval [CI]: 70.7–73.4%). The acceptance of test increased from 35.9% (95% CI: 31.7–40.4%) in 2002 to the peak of 82.6% (95% CI: 78.6–86.8%) in 2009 (P < 0.001). The overall HIV prevalence over the decade was 0.70% (95% CI: 0.55–0.87%). The prevalence high at 1.11% (95% CI: 0.23–3.24%) in 2002 and reduced to 0.37% (95% CI: 0.12–0.87%) in 2011 (P < 0.001). Only 0.57% of male partners tested for HIV over this time period.Conclusion:Strategies to improve acceptance of testing in pregnant women should be included in the Indian guidelines. The male partners do not get tested. Thus, this component needs to be strengthened - by targeted interventions for male spouses - to make the program more effective.
Worldwide 20-30% of labour cases are induced. We conducted an analysis to evaluate the success of labour induction for indicated preterm birth A prospective observational study was conducted among 50 patients admitted in the Department of OBGY, MGM Medical College and Hospital, Aurangabad from 1st March 2019 to 31st March 2020. There was a total of 50 deliveries during this period. The preterm induction majorly includes 20-34 years as this is the commonest reproductive age group seen in our hospital. More number of Hindus underwent induction. Multigravida requires induction more as compared to primigravida. More number of patients were induced between 32-36 weeks, reason being PPROM, severe preeclampsia, IUD and severe FGR. Vaginal delivery is more likely irrespective of bishop score. Induction of labour remains relevant obstetrics procedure and its outcome will depend on proper choice of patients and close intrapartum monitoring
A recent rise in the incidence of a vector borne viral disease, Dengue Disease, in South Asian countries has also shown an impact on the pregnant population in these regions. There are four known Dengue virus serotypes, the predominant ones being DENV- 2 and DENV-3, when present during pregnancy could be associated with complications like preterm birth, maternal mortality and morbidity and adverse neonatal outcomes.[1]. We aimed to study the outcomes in the pregnant patients that presented to our institution with the Dengue disease. Methods: A 6-month (1/9/2019 – 29/2/2020) study was undertaken during the months of high prevalence of the Dengue disease in our region. Clinical, laboratory, maternal and foetal outcomes were studied among serologically positive dengue mothers treated at MGM Hospital, Aurangabad. A total of 25 patients were found to have Dengue disease during the study period. NS1Ag and IGM serological analysis results were used to achieve diagnosis and early management. 7 patients had symptomatic thrombocytopenia and needed platelet transfusions. Majority of our patients had favourable outcomes. 3 mothers died succumbing to the multiorgan failure. Favourable maternal and foetal outcomes could be achieved with early diagnosis of suspected Dengue disease with both NS1Ag and IGM serological analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.